BiotechTube
Home/Vironexis Biotherapeutics/Timothy P. Cripe, M.D., Ph.D.
TP

Timothy P. Cripe, M.D., Ph.D.

Co-Founder & Board Member

Vironexis Biotherapeutics

Therapeutic Areas

OncologyAutoimmune Disorders

Vironexis Biotherapeutics Pipeline

DrugIndicationPhase
VNX-101CD19+ leukemias and lymphomasPhase 1/2
VNX-102Multiple MyelomaIND-Enabling
VNX-103B-cell LymphomaIND-Enabling
VNX-201NeuroblastomaPreclinical
VNX-202Her2+ cancersPreclinical
VNX-203Gastric CancerPreclinical
VNX-204Pancreatic CancerPreclinical
VNX-205Prostate CancerPreclinical

Leadership Team at Vironexis Biotherapeutics

SV
Samit Varma
CEO & Board Member
BK
Brian Kaspar, Ph.D.
Co-Founder & Board Member
AR
Allen Reha
Chief Development Officer
View full Vironexis Biotherapeutics profile